UK Government Announces Plan to Phase Out Animal Testing

Tue Nov 11 2025 15:30:19 GMT+0200 (Eastern European Standard Time)

The UK government is set to implement a strategy aiming to eliminate animal experiments, pledging to replace certain tests with alternatives by the end of the year.

In a groundbreaking initiative, the UK government has outlined plans to phase out animal testing as part of its manifesto commitment. By the end of 2023, it aims to replace specific animal tests with innovative alternatives, including human cell-based methods and artificial intelligence approaches. The strategy involves reducing the use of dogs and primates in medical testing by 35% by 2030, aligning with the growing shift towards humane scientific practices. However, experts express concerns regarding the feasibility and safety implications of fully replacing animal experiments.

UK Government Announces Plan to Phase Out Animal Testing

The UK government is set to implement a strategy aiming to eliminate animal experiments, pledging to replace certain tests with alternatives by the end of the year.

Labour’s manifesto commitment will see the government significantly reduce animal testing, with specific targets to lower the use of dogs and non-human primates in medical research by at least 35% by 2030.

Science Minister Lord Vallance envisions a future where animal use in experiments is highly minimized, citing advances such as AI and human tissue-based studies. By 2025, major safety tests on animals are expected to be phased out entirely, transitioning to lab methods using human cells.

Animal testing in the UK peaked in 2015 at 4.14 million procedures, with recent years showing a decline, now plateauing at 2.88 million. With concerns that some biological complexities can’t be accurately recreated without using animals, the government faces skepticism from parts of the scientific community regarding the effectiveness of alternative methods.

Critics, including Prof. Frances Balkwill of Barts Cancer Institute, express doubt over whether rigorous animal testing can be fully replaced without compromising safety in medical advancements. They contend that understanding complex biological interactions, such as cancer, necessitates the use of animal models.

Others, like Prof. Robin Lovell-Badge, caution against rushing toward alternatives, arguing that it may hinder scientific progress in critical areas.

The initiative has received a cautious welcome from animal welfare organizations like the RSPCA but emphasizes the need for the government to effectively implement these ambitious plans.

As the government moves forward with its roadmap, collaboration with scientists, industry leaders, and civil society will be crucial in progressing toward this significant paradigm shift in research methodologies.